US Patent Issued to MTI Biotech on May 26 for "Compositions and methods of use of gamma-ketoaldheyde scavengers for treating, preventing or improving fibrosis of the liver" (Iowa, Tennessee Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,636,269, issued on May 26, was assigned to MTI Biotech Inc. (Ames, Iowa).

"Compositions and methods of use of gamma-ketoaldheyde scavengers for treating, preventing or improving fibrosis of the liver" was invented by John Rathmacher (Story City, Iowa), Naji Abumrad (Nashville, Tenn.) and Charles Flynn (Nashville, Tenn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods and compositions for use in treating, attenuating, preventing or improving liver fibrosis in a subject are described. The compounds of the present invention are gamma-ketoaldehyde scavengers."

The patent was filed on June 23, 2023, under Application No. 18/213,416.

*For further infor...